FindTrial
Sign In

Identification of Neoantigens and Immune Responses in Breast Cancer Patients Receiving Postoperative Adjuvant Therapy

Identification of Neoantigens and Immune Responses in Breast Cancer Patients Receiving Postoperative Adjuvant Therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112524
Enrollment
Unknown
Registered
2025-11-16
Start date
2025-11-17
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Breast Cancer Observation Group:None

Sponsors

Women’s Hospital, Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.18 years old <= age <=75 years old; 2. Female patients who need to have their breast cancer tumors removed; 3. Complete case data;

Exclusion criteria

Exclusion criteria: 1.Hepatitis B, syphilis, or HIV infection or carrier status; 2.History of immune-related diseases, such as systemic lupus erythematosus; 3.Acute or chronic infections prior to postoperative adjuvant therapy; 4.History of other malignant tumors; 5.Current participation in other clinical trials; 6.Considered by investigators to be inappropriate for participation in the present study for other reason;

Design outcomes

Primary

MeasureTime frame
Prognosis;—

Countries

China

Contacts

Public ContactWeiguo Lv

Women’s Hospital, Zhejiang University School of Medicine

lbwg@zju.edu.cn+86 571 8701 1135

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026